Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4212
Gene Symbol: MEIS2
MEIS2
0.110 Biomarker disease BEFREE By reviewing this patient and previous patients with MEIS2 point mutations, we found that feeding difficulty with gastro-esophageal reflux appears to be one of the core clinical features of MEIS2 haploinsufficiency, in addition to intellectual disability, cleft palate and cardiac septal defect. 27225850 2016
Entrez Id: 55636
Gene Symbol: CHD7
CHD7
0.110 Biomarker disease HPO
Entrez Id: 4212
Gene Symbol: MEIS2
MEIS2
0.110 Biomarker disease HPO
Entrez Id: 59330
Gene Symbol: GER
GER
0.100 Biomarker disease BEFREE Acid reflux is common in patients with diabetes.GER is associated with the existence of obesity rather than hyperglycemia. 30458553 2020
Entrez Id: 93986
Gene Symbol: FOXP2
FOXP2
0.100 GeneticVariation disease GWASCAT Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases. 31527586 2019
Entrez Id: 479
Gene Symbol: ATP12A
ATP12A
0.100 Biomarker disease BEFREE Vonoprazan versus proton-pump inhibitors for healing gastroesophageal reflux disease: A systematic review. 30883868 2019
Entrez Id: 59330
Gene Symbol: GER
GER
0.100 Biomarker disease BEFREE Gastroesophageal reflux disease (GERD) is defined as GER causing troublesome symptoms or complications. 30676525 2019
Entrez Id: 59330
Gene Symbol: GER
GER
0.100 Biomarker disease BEFREE Gastroesophageal reflux (GER) is increasingly recognized as an exacerbating or causal factor in several respiratory diseases. 30312588 2019
Entrez Id: 102724373
Gene Symbol: LINC02831
LINC02831
0.100 GeneticVariation disease GWASCAT Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases. 31527586 2019
Entrez Id: 479
Gene Symbol: ATP12A
ATP12A
0.100 GeneticVariation disease BEFREE Gastroesophageal reflux disease (GERD) can be treated using a vonoprazan-first strategy (first-line treatment with vonoprazan), or esomeprazole-first/rabeprazole-first strategies (first-line treatment with proton-pump inhibitors [PPIs], esomeprazole/rabeprazole, followed by a switch to vonoprazan). 31396703 2019
Entrez Id: 338
Gene Symbol: APOB
APOB
0.100 GeneticVariation disease GWASCAT Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases. 31527586 2019
Entrez Id: 59330
Gene Symbol: GER
GER
0.100 Biomarker disease BEFREE Gastroesophageal reflux (GER), excessive crying, and constipation are common gastrointestinal symptoms in infancy of multifactorial origin in which psychosocial stress factors play an important role. 31517718 2019
Entrez Id: 495
Gene Symbol: ATP4A
ATP4A
0.100 Biomarker disease BEFREE We aimed to assess the dynamic changes in the peripheral T lymphocytes and lymphocytes infiltrating the esophageal mucosa after treatment with proton-pump inhibitor (PPI) in patients with GERD. 30119091 2019
Entrez Id: 495
Gene Symbol: ATP4A
ATP4A
0.100 GeneticVariation disease BEFREE Gastroesophageal reflux disease (GERD) can be treated using a vonoprazan-first strategy (first-line treatment with vonoprazan), or esomeprazole-first/rabeprazole-first strategies (first-line treatment with proton-pump inhibitors [PPIs], esomeprazole/rabeprazole, followed by a switch to vonoprazan). 31396703 2019
Entrez Id: 1557
Gene Symbol: CYP2C19
CYP2C19
0.100 GeneticVariation disease BEFREE Children ages 6-17 years old with clinician-diagnosed asthma and mild GERD symptoms will submit a saliva sample for CYP2C19 genotyping. 30659924 2019
Entrez Id: 11120
Gene Symbol: BTN2A1
BTN2A1
0.100 GeneticVariation disease GWASCAT Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases. 31527586 2019
Entrez Id: 221935
Gene Symbol: SDK1
SDK1
0.100 GeneticVariation disease GWASCAT Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases. 31527586 2019
Entrez Id: 55534
Gene Symbol: MAML3
MAML3
0.100 GeneticVariation disease GWASCAT Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases. 31527586 2019
Entrez Id: 59330
Gene Symbol: GER
GER
0.100 PosttranslationalModification disease BEFREE Anti-reflux mucosectomy (ARMS) is a newfangled minimally invasive technique, with successful outcomes for the management of Gastroesophageal Reflux (GER). 31834663 2019
Entrez Id: 3899
Gene Symbol: AFF3
AFF3
0.100 GeneticVariation disease GWASCAT Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases. 31527586 2019
Entrez Id: 59330
Gene Symbol: GER
GER
0.100 GeneticVariation disease BEFREE To objectively test a hypothesis that all EAE types (air swallows, supra-gastric belches and gastric belches) can be associated with GERD-like symptoms, we removed the impedance "tags" from the GER episodes (placed during autoscan) and instead tagged either air-swallows, supra-gastric belches or gastric belches in each of 3 copies of the 24-hour impedance tracing for two infant patients who presented with symptoms suggestive of GER as an etiology. 31567648 2019
Entrez Id: 55295
Gene Symbol: KLHL26
KLHL26
0.100 GeneticVariation disease GWASCAT Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases. 31527586 2019
Entrez Id: 101929660
Gene Symbol: LINC02109
LINC02109
0.100 GeneticVariation disease GWASCAT Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases. 31527586 2019
Entrez Id: 54067
Gene Symbol: C21orf62-AS1
C21orf62-AS1
0.100 GeneticVariation disease GWASCAT Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases. 31527586 2019
Entrez Id: 5142
Gene Symbol: PDE4B
PDE4B
0.100 GeneticVariation disease GWASCAT Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases. 31527586 2019